טוען...
Successful Use of Recombinant Activated Factor VII to Reverse Ticagrelor-Induced Bleeding Risk: A Case Report
Management of ticagrelor-associated bleeding is challenging, especially in neurosurgery. Platelet transfusion is inefficient and no antidote is currently available. We report here the first case of recombinant activated factor VII (rFVIIa) use to bypass ticagrelor-induced platelet inhibition. A woma...
שמור ב:
| הוצא לאור ב: | TH Open |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Georg Thieme Verlag KG
2018
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6524896/ https://ncbi.nlm.nih.gov/pubmed/31249959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0038-1672211 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|